Nextcure website screenshot

Nextcure

NextCure, Inc. (NASDAQ NXTC) is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunomedicines to treat cancer and other immune-related diseases. The company uses its FIND-IO platform to identify and characterize immunomodulatory targets and biological pathways, advancing a pipeline of immunotherapy drug candidates. NextCure surfaced in the API Evangelist network as a portfolio company of canaan-partners. Enrichment probe (2026-07-20) found no public developer API, API documentation, or developer portal; this is a biopharmaceutical R&D organization with no programmatic API surface to catalog.

Nextcure is profiled on the APIs.io network. Tagged areas include Company, Biopharmaceutical, Immunotherapy, Oncology, and Healthcare.

🌐 Visit website 📡 Source on GitHub
2.2/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-20 · rubric v0.12.0
0 APIs
CompanyBiopharmaceuticalImmunotherapyOncologyHealthcareDrug DevelopmentBiotechnology

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-20 · rubric v0.12.0
Composite quality — 2.2/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 0.0 / 17
Access Clarity 0.0 / 17
Operational Transparency 0.0 / 11
Contract Governance 0.0 / 10
Discoverability 4.3 / 9
Regulatory Posture 0.0 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
Documented Reversibility 0 / 6
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/nextcure: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Company 2

The organization behind the API

Website
Website
 InvestorRelations
InvestorRelations

Source (apis.yml)

apis.yml Raw ↑ 
aid: nextcure
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/nextcure.png
name: Nextcure
description: NextCure, Inc. (NASDAQ NXTC) is a clinical-stage biopharmaceutical company focused on discovering and developing
  novel immunomedicines to treat cancer and other immune-related diseases. The company uses its FIND-IO platform to identify
  and characterize immunomodulatory targets and biological pathways, advancing a pipeline of immunotherapy drug candidates.
  NextCure surfaced in the API Evangelist network as a portfolio company of canaan-partners. Enrichment probe (2026-07-20)
  found no public developer API, API documentation, or developer portal; this is a biopharmaceutical R&D organization with
  no programmatic API surface to catalog.
url: https://raw.githubusercontent.com/api-evangelist/nextcure/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- canaan-partners
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Biopharmaceutical
- Immunotherapy
- Oncology
- Healthcare
- Drug Development
- Biotechnology
apis: []
common:
- type: Website
  url: https://www.nextcure.com
- type: InvestorRelations
  url: https://ir.nextcure.com
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-20'
  status: nochange
  artifacts_added: 0
  pass: local-v1